GO:0060538 skeletal muscle organ development: Myogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060538 (skeletal muscle organ development) describes the biological process by which a skeletal muscle organ forms, from myogenic precursor specification through myoblast fusion and maturation into a functional contractile organ.
• Skeletal muscle is not only a contractile tissue but also a secretory and endocrine organ that communicates with other organs during development and in adult physiology.
• The process is controlled by myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6), paired-box factors (PAX3, PAX7), and multiple signaling pathways including WNT, BMP, FGF, and IGF.
• MicroRNAs and inter-organ crosstalk add additional layers of regulation to skeletal muscle organ development.
• Disruption of skeletal muscle organ development contributes to myopathies, metabolic disease, and developmental syndromes, making it a key target for functional genomics.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in this process.
Description
Skeletal muscle organ development (GO:0060538) is the biological process that builds a skeletal muscle organ, beginning with the specification of myogenic precursors and ending with a mature, innervated, contractile tissue. This process is fundamental to locomotion, posture, thermogenesis, and whole-body metabolism, and it is increasingly recognized as a hub of inter-organ communication during prenatal and postnatal life. Because skeletal muscle is also a secretory organ that releases myokines affecting distant tissues, defects in its development can have systemic consequences beyond the muscle itself. Understanding GO:0060538 therefore matters for developmental biology, regenerative medicine, metabolic research, and the study of neuromuscular disease. The process is orchestrated by a conserved transcriptional network, including PAX3, PAX7, MYOD1, MYF5, MYOG, and MYF6, together with signaling inputs from WNT, BMP, FGF, and IGF pathways. MicroRNAs and tissue-tissue crosstalk further refine the timing and extent of muscle formation. In this article we define GO:0060538, summarize its molecular and cellular basis, highlight its disease relevance, and outline how CRISPR-based models and modern omics methods can be used to study it.
skeletal muscle organ development At A Glance
| GO ID | GO:0060538 |
|---|---|
| GO term | skeletal muscle organ development |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Formation and maturation of a skeletal muscle organ from myogenic precursors |
| Key cell types | Myoblasts, myocytes, myofibers, satellite cells, fibroblasts, endothelial cells |
| Key regulators | PAX3, PAX7, MYOD1, MYF5, MYOG, MYF6, MRF4, microRNAs |
| Related processes | Myogenesis, myoblast fusion, muscle regeneration, muscle hypertrophy |
| Disease relevance | Congenital myopathies, muscular dystrophies, metabolic disorders, developmental syndromes |
What Is GO:0060538?
GO:0060538 (skeletal muscle organ development) is the biological process by which a skeletal muscle organ is formed and matures. It encompasses the specification of myogenic precursor cells, their proliferation and migration, commitment to the myogenic lineage, differentiation and fusion into multinucleated myofibers, and the organization of these fibers into a functional organ with connective tissue, vasculature, and innervation. The term is a developmental process term in the biological_process aspect of the Gene Ontology and is distinct from adult muscle hypertrophy or regeneration, although the underlying transcriptional programs overlap.
Why Is skeletal muscle organ development Important in Cell Biology?
GO:0060538 is important because skeletal muscle is essential for movement, posture, breathing, and whole-body energy homeostasis, and its developmental failure or dysregulation underlies a broad spectrum of human disorders. Skeletal muscle also functions as a secretory and endocrine organ, releasing myokines that influence adipose tissue, liver, bone, and brain, so developmental defects can propagate systemically. In agriculture and comparative biology, abnormal skeletal muscle organ development is linked to myopathies such as woody breast in broilers, illustrating its economic and veterinary relevance. Finally, because the transcriptional and signaling logic of muscle development is conserved, studying GO:0060538 provides mechanistic insight into regeneration, aging, and metabolic disease.
• Skeletal muscle organ development is required for locomotion, posture, and thermogenesis.
• It establishes the myofiber number and size that determine adult muscle mass and function.
• Defects in this process cause congenital myopathies and muscular dystrophies.
• Skeletal muscle acts as an endocrine organ, so developmental defects can affect distant tissues.
• Inter-organ crosstalk during development influences muscle and non-muscle organs.
• MicroRNAs provide an additional regulatory layer that can be targeted experimentally.
• Comparative studies in poultry link abnormal muscle development to myopathies such as woody breast.
• Understanding GO:0060538 informs regenerative medicine and cell-based therapies.
• It provides a framework for interpreting single-cell and spatial transcriptomics of muscle.
• CRISPR screens can identify novel regulators within this process.
What Happens During skeletal muscle organ development?
Specification of myogenic precursors
In simple terms: Early embryonic cells are told to become muscle-forming cells.
During early embryogenesis, signals from surrounding tissues instruct a subset of mesodermal cells to adopt a myogenic fate. PAX3 and PAX7 mark these precursors, and WNT and BMP signaling from the neural tube and lateral plate mesoderm help pattern the somite into the dermomyotome, the source of skeletal muscle progenitors. This specification step is a prerequisite for all subsequent steps of GO:0060538 and is conserved across vertebrates.
Proliferation and migration of myoblasts
In simple terms: Muscle-forming cells multiply and move to where the muscle will form.
Once specified, myoblasts proliferate under the control of FGF and IGF signaling and migrate to their target sites. PAX3 and PAX7 maintain the proliferative progenitor pool, while MYF5 and MYOD1 initiate the myogenic program. Disruption of this phase reduces the progenitor pool and can lead to hypoplastic muscles.
Differentiation and myoblast fusion
In simple terms: Muscle cells stop dividing and fuse together into long muscle fibers.
Myoblasts exit the cell cycle, express MYOG and MYF6, and fuse to form multinucleated myofibers. This fusion step requires membrane remodeling proteins and is accompanied by expression of contractile proteins such as actin and myosin. The transition from mononucleated myoblasts to multinucleated myofibers is a defining event of skeletal muscle organ development.
Maturation and organization into a muscle organ
In simple terms: The new muscle fibers organize into a complete muscle with nerves and blood vessels.
Nascent myofibers become innervated, acquire a vascular supply, and organize with connective tissue into a functional muscle organ. This maturation phase involves the establishment of the neuromuscular junction and the formation of tendons and fascia. Inter-organ communication, including signals from the developing ear and other tissues, has been shown to influence this process.
Postnatal growth and regeneration
In simple terms: After birth, muscles grow and can repair themselves using resident stem cells.
Although GO:0060538 primarily covers embryonic development, the same transcriptional network operates postnatally in satellite cells to support growth and regeneration. Dietary protein and resistance exercise promote muscle hypertrophy through mTOR-dependent mechanisms, linking developmental programs to adult physiology. MicroRNAs such as miR-1, miR-133, and miR-206 modulate these postnatal processes.
Key Genes Involved in GO:0060538 skeletal muscle organ development
The following genes are well-established regulators of skeletal muscle organ development and are commonly studied in functional genomics experiments.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAX3 | Specification of myogenic precursors | Marker of early muscle progenitors; knockout causes muscle defects |
| PAX7 | Maintenance of satellite cells and progenitors | Key target for regeneration studies |
| MYF5 | Initiation of myogenic program | Early determination factor; knockout delays myogenesis |
| MYOD1 | Myogenic determination and differentiation | Master regulator; overexpression can reprogram fibroblasts |
| MYOG | Terminal differentiation and fusion | Marker of differentiated myocytes |
| MYF6 | Myofiber maturation | Required for late muscle differentiation |
| MRF4 | Myogenic regulatory factor | Overlaps with MYF6 in maturation |
| MEF2C | Transcriptional co-activator of myogenesis | Integrates calcium signaling with muscle gene expression |
| IGF1 | Promotes myoblast proliferation and hypertrophy | Anabolic signal; target for muscle growth studies |
| MSTN | Negative regulator of muscle mass | Knockout increases muscle mass; therapeutic target |
| WNT1 | Induces myogenesis in somites | Signaling input for early muscle specification |
| BMP4 | Inhibits myogenesis | Patterning signal; balance with WNT is critical |
| FGF2 | Stimulates myoblast proliferation | Delays differentiation; used in culture |
| MIR1 | MicroRNA regulating muscle differentiation | Post-transcriptional control of myogenesis |
| MIR133 | MicroRNA regulating proliferation | Modulates myoblast expansion |
| MIR206 | Muscle-specific microRNA | Promotes differentiation; biomarker |
| DMD | Dystrophin; structural protein | Mutations cause Duchenne muscular dystrophy |
| MYH7 | Myosin heavy chain | Contractile protein; marker of slow fibers |
How Is skeletal muscle organ development Regulated?
Skeletal muscle organ development is regulated at multiple levels. Transcriptionally, the myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6) form a hierarchical network with PAX3 and PAX7. Signaling inputs include WNT, BMP, FGF, and IGF, which balance proliferation and differentiation. Post-transcriptionally, microRNAs such as miR-1, miR-133, and miR-206 fine-tune the timing of differentiation. In adult muscle, mTOR signaling integrates nutrient and mechanical cues to control hypertrophy, and dietary protein plus resistance exercise promotes muscle growth through this pathway. Inter-organ communication, including signals from other developing organs, also modulates muscle development.
skeletal muscle organ development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMD | Duchenne muscular dystrophy | KO or point-mutation in DMD; muscle histology |
| MYOD1 | Myopathy with impaired differentiation | Knockout and overexpression in myoblasts |
| PAX7 | Satellite cell dysfunction | Conditional knockout in satellite cells |
| MSTN | Muscle hypertrophy / cachexia | Knockout increases muscle mass |
| IGF1 | Muscle growth disorders | Overexpression and KO models |
Congenital myopathies and muscular dystrophies
Disruption of genes that control skeletal muscle organ development causes congenital myopathies and muscular dystrophies. For example, mutations in DMD cause Duchenne muscular dystrophy, and defects in myogenic regulatory factors lead to muscle hypoplasia. Animal models such as the woody breast myopathy in broilers show that abnormal muscle development has measurable pathological consequences.
Metabolic and endocrine disorders
Because skeletal muscle is a secretory organ, impaired muscle development can alter systemic metabolism. Myokines released by muscle influence adipose tissue, liver, and brain function, linking GO:0060538 to obesity and insulin resistance. Inter-organ crosstalk during development further connects muscle to metabolic homeostasis.
Developmental syndromes with muscle involvement
Several developmental syndromes feature skeletal muscle abnormalities, including those affecting ear and craniofacial development. Studies in animal models show that skeletal muscle plays a role in prenatal inter-organ communication, and its dysfunction can affect neighboring structures. This highlights the need to study GO:0060538 in a whole-organism context.
From skeletal muscle organ development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for myogenesis? | CRISPR knockout in myoblast cell lines |
| Does a specific mutation affect muscle development? | Point-mutation knock-in in mice or cells |
| Where and when is a gene expressed? | Tagged knock-in with fluorescent reporter |
| Does overexpression drive hypertrophy? | Overexpression cell model or transgenic mouse |
| Which genes regulate muscle development? | CRISPR library screening in myoblasts |
| How does a gene affect inter-organ crosstalk? | Conditional KO in mouse models |
How to Study the skeletal muscle organ development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome | Identify differentially expressed genes during myogenesis |
| Single-cell RNA-seq | Cell-type-specific expression | Map progenitor and myofiber states |
| Proteomics | Protein abundance | Validate transcriptomic findings |
| Immunofluorescence | Protein localization | Assess myofiber morphology |
| CRISPR knockout | Gene function | Test requirement for myogenesis |
| CRISPR knock-in | Tagged protein expression | Track endogenous protein |
| CRISPR library screen | Pooled gene function | Discover novel regulators |
Transcriptomics and single-cell RNA-seq
RNA-seq and single-cell RNA-seq can profile gene expression during muscle development, identifying novel regulators and cell states. These methods are widely used to study GO:0060538 in embryos and in differentiating myoblasts.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics measures protein abundance and post-translational modifications during myogenesis, complementing transcriptomic data.
Imaging and histology
Immunofluorescence and in situ hybridization visualize myofiber organization, innervation, and marker expression in developing muscle.
Functional perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of candidate genes in muscle development.
How CRISPR Can Be Used to Study GO:0060538 skeletal muscle organ development
Knockout
CRISPR knockout of candidate genes in myoblast cell lines or animal models can determine whether a gene is required for skeletal muscle organ development. For example, knocking out MYOD1 or PAX7 impairs myogenesis, and knockout models are widely used to study muscle disease genes.
Point Mutation
Point mutations can model specific human variants associated with muscle disorders. CRISPR-mediated base editing or homology-directed repair introduces precise mutations to test their effect on muscle development.
Knock-in
Knock-in of fluorescent or epitope tags allows visualization and purification of endogenous proteins during muscle development. This is useful for studying dynamic processes such as myoblast fusion.
Overexpression
Overexpression of myogenic factors or signaling molecules can drive or enhance muscle formation. For instance, overexpression of IGF1 or MYOD1 promotes myogenic differentiation in cell models.
How EDITGENE Supports skeletal muscle organ development Research
Researchers studying skeletal muscle organ development-related genes often need to determine whether a candidate gene is causally involved in myogenesis, how a specific patient variant affects protein function, or which genes regulate muscle formation in a pooled format. EDITGENE provides end-to-end CRISPR services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle organ development research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FXR1 Knockout HEK293 Cell Line | EDJ-KQ2559 | Human | 8087 | Details Get a Quote |
| DES Knockout HEK293 Cell Line | EDJ-KQ3759 | Human | 1674 | Details Get a Quote |
| LARGE1 Knockout HEK293 Cell Line | EDJ-KQ6508 | Human | 9215 | Details Get a Quote |
| SCN11A Knockout HEK293 Cell Line | EDJ-KQ7360 | Human | 11280 | Details Get a Quote |
| MYMX Knockout HEK293 Cell Line | EDJ-KQ14343 | Human | 101929726 | Details Get a Quote |
| FXR1 Knockout A-549 Cell Line | EDJ-KQ23216 | Human | 8087 | Details Get a Quote |
| FXR1 Knockout HCT 116 Cell Line | EDJ-KQ23217 | Human | 8087 | Details Get a Quote |
| FXR1 Knockout HeLa Cell Line | EDJ-KQ23218 | Human | 8087 | Details Get a Quote |
| DES Knockout HCT 116 Cell Line | EDJ-KQ25840 | Human | 1674 | Details Get a Quote |
| DES Knockout HeLa Cell Line | EDJ-KQ25841 | Human | 1674 | Details Get a Quote |
| LARGE1 Knockout A-549 Cell Line | EDJ-KQ30653 | Human | 9215 | Details Get a Quote |
| SCN11A Knockout HeLa Cell Line | EDJ-KQ55624 | Human | 11280 | Details Get a Quote |
| DES Knockout A-549 Cell Line | EDJ-KQ61554 | Human | 1674 | Details Get a Quote |
| SCN11A Knockout A-549 Cell Line | EDJ-KQ64123 | Human | 11280 | Details Get a Quote |
| SCN11A Knockout HCT 116 Cell Line | EDJ-KQ72567 | Human | 11280 | Details Get a Quote |
Frequently Asked Questions About skeletal muscle organ development
What is GO:0060538?
GO:0060538 is the Gene Ontology term for skeletal muscle organ development, the biological process by which a skeletal muscle organ forms and matures.
What genes are involved in skeletal muscle organ development?
Key genes include PAX3, PAX7, MYF5, MYOD1, MYOG, MYF6, and MRF4, along with signaling molecules such as IGF1, WNT1, and BMP4.
Why is skeletal muscle organ development important?
It is essential for movement, posture, thermogenesis, and whole-body metabolism, and its disruption causes myopathies and metabolic disorders.
How is skeletal muscle organ development regulated?
It is regulated by a transcriptional network of myogenic factors, signaling pathways (WNT, BMP, FGF, IGF), and microRNAs.
What diseases are linked to defects in skeletal muscle organ development?
Congenital myopathies, muscular dystrophies, and metabolic disorders are linked to defects in this process.
What methods are used to study skeletal muscle organ development?
RNA-seq, single-cell RNA-seq, proteomics, imaging, and CRISPR-based perturbation are commonly used.
Can CRISPR be used to study skeletal muscle organ development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in this process.
What is the role of microRNAs in skeletal muscle development?
MicroRNAs such as miR-1, miR-133, and miR-206 regulate myoblast proliferation and differentiation.
How does skeletal muscle communicate with other organs?
Skeletal muscle secretes myokines that affect adipose tissue, liver, bone, and brain, and inter-organ crosstalk influences its development.
What model systems are used to study skeletal muscle organ development?
Cell lines, zebrafish, chicken, and mouse models are commonly used, including knockout and transgenic models.
Conclusion
GO:0060538 (skeletal muscle organ development) is a central biological process that integrates transcriptional, signaling, and microRNA networks to build a functional muscle organ. Its importance extends from developmental biology to metabolic and neuromuscular disease, and it is increasingly studied with CRISPR-based functional genomics. EDITGENE provides comprehensive CRISPR services to help researchers dissect the genes and mechanisms underlying this process.
References
- 1. Pedersen BK et al.. 2012. Muscles, exercise and obesity: skeletal muscle as a secretory organ.. Nat Rev Endocrinol 8(8):457-65 PMID: 22473333
- 2. Jia L et al.. 2022. Internal organ and skeletal muscle development in commercial broilers with woody breast myopathy.. Poult Sci 101(9):102012 PMID: 35896053
- 3. Zhang Z et al.. 2023. [The role and regulatory mechanism of tissue and organ crosstalk on skeletal muscle development: a review].. Sheng Wu Gong Cheng Xue Bao 39(4):1502-1513 PMID: 37154319
- 4. Kablar B. 2023. Skeletal Muscle's Role in Prenatal Inter-organ Communication: A Phenogenomic Study with Qualitative Citation Analysis.. Adv Anat Embryol Cell Biol 236:1-19 PMID: 37955769
- 5. Stokes T et al.. 2018. Recent Perspectives Regarding the Role of Dietary Protein for the Promotion of Muscle Hypertrophy with Resistance Exercise Training.. Nutrients 10(2) PMID: 29414855
- 6. Liu N et al.. 2015. Regulation of skeletal muscle development and disease by microRNAs.. Results Probl Cell Differ 56:165-90 PMID: 25344671
- 7. Rot I et al.. 2017. Role of skeletal muscle in ear development.. Histol Histopathol 32(10):987-1000 PMID: 28271491
- 8. Karstoft K et al.. 2016. Skeletal muscle as a gene regulatory endocrine organ.. Curr Opin Clin Nutr Metab Care 19(4):270-5 PMID: 27101470
